Blog

Photo from KidneyCAN/X

Jul 15, 2024, 07:42

KCRS24 Biotech Showcase – KidneyCAN

KidneyCAN shared a post on X: .

“KCRS24 Biotech Showcase.

Casdatifan (AB521), Dimitry Nuyten
SRK-181 with Pembro, Lu Gan
IL-2 Receptor Agonist, Alex Azrilevich
Antibody Targeting ENPP3, Chet Bohac
Novel Cell Therapy, Levi Gray-Rupp
Genomic and Transcriptomic Analysis, Pavlos Msaouel
Emerging Therapies, Kim Allman.”

KCRS24 Biotech Showcase - KidneyCAN

Source: KidneyCAN/X

AB521 Alex Azrilevich Antibody Targeting ENPP3 cancer Casdatifan Chet Bohac Dimitry Nuyten Emerging Therapies IL-2 Receptor Agonist KidneyCAN Kim Allman Levi Gray-Rupp Lu Gan Novel Cell Therapy OncoDaily Oncology Pavlos Msaouel SRK-181 with Pembro Transcriptomic Analysis

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage